Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
About Global Med Technologies(R), Inc.
Global Med Technologies, Inc. is an international medical software companywhich develops regulated and non-regulated software products and services forthe healthcare industry. As a leading provider of blood and laboratorysoftware applications and services, Global Med's products are deployed in 20countries and serve over 1,600 transfusion centers, blood banks andlaboratories.
Advertisement
Global Med's domestic companies are Wyndgate Technologies(R), whichprovides Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R),SafeTrace Tx(R) and ElDorado Donor(TM) software products; eDonor(R), whichprovides a web-based donor relationship management system that integratesrecruitment, scheduling, retention and fulfillment for national as well aslocal community blood centers and hospitals; and PeopleMed(TM), Inc., whichimplements cost-effective customized software validation, consulting andcompliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer ofdonor center and transfusion management systems as well as cellular therapysoftware, laboratory information systems and quality assurance medicalsoftware systems internationally. Inlog's products include EdgeBlood*,EdgeTrack*, EdgeCell, EdgeLab and SapaNet.
For more information about Global Med's products and services, please call800-996-3428 or visit http://www.globalmedtech.com, http://www.peoplemed.com,http://www.inlog.com, http://www.eDonor.com, and http://www.wyndgate.com.
*FDA 510(k) clearance required prior to sales in the U.S.
This news release may include statements that constitute forward-lookingstatements, usually containing the words "believe," "estimate," "project,""expects" or similar expressions. These statements are made pursuant to thesafe harbor provisions of the Private Securities Litigation Reform Act of1995. Forward-looking statements inherently involve risks and uncertaintiesthat could cause actual results to differ materially from the forward-lookingstatements. By making these forward-looking statements, the Companyundertakes no obligation to update these statements for revisions or changesafter the date of this news release.
SOURCE Global Med Technologies, Inc.
